Abstract A032: Interstitial insulin enrichment drives pancreatic cancer growth by enhancing cancer cell metabolic plasticity

Abstract Metabolic diseases, such as type 2 diabetes, insulin resistance, and obesity, often coexist with pancreatic ductal adenocarcinoma (PDAC) and predict poor survival. Using a mouse model of diet-induced obesity, we showed that a high-fat diet (HFD) consumption that induces hyperinsulinemia, but not hyperglycemia, in mice accelerated the growth of xenografted patient-derived PDAC organoids (PDOs). Strikingly, even in the fasting state, insulin was highly enriched in the tumor interstitial fluid of pancreatic tumors under HFD. Modelling this elevated interstitial insulin concentration in vitro significantly increased PDO growth regardless of glucose levels. Mechanistically, chronic high-insulin exposure robustly enhances metabolic plasticity and nutrient utilization in PDOs by selectively upregulating distinct metabolic pathways in response to differences in extracellular glucose levels. Thus, the presence of robust insulin levels continuously supports tumor growth as glucose availability changes. Specifically, under low-glucose conditions, elevated insulin activates nutrient uptake machinery and amino acid metabolism, whereas it promotes aerobic glycolysis in high-glucose conditions. Pharmacological inhibition of these metabolic pathways attenuated insulin-mediated growth. Our study identifies insulin enrichment in the tumor-interstitial fluid as an important driver of metabolic adaptation in PDAC cells. Citation Format: Jeffrey SH. Lin, James D. Johnson, Christoph H. Borchers, David F. Schaeffer, Janel L. Kopp. Interstitial insulin enrichment drives pancreatic cancer growth by enhancing cancer cell metabolic plasticity [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_3):Abstract nr A032.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-09-28
DOI
https://doi.org/10.1158/1538-7445.pancreatic25-a032
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A032: Interstitial insulin enrichment drives pancreatic cancer growth by enhancing cancer cell metabolic plasticity

James D. Johnson, Christoph H. Borchers, Jeffrey S.H. Lin, Janel L. Kopp et al.
Cancer Research
Cancer, Hypoxia, and Metabolism
article

Abstract A032: Interstitial insulin enrichment drives pancreatic cancer growth by enhancing cancer cell metabolic plasticity

James D. Johnson, Christoph H. Borchers, Jeffrey S.H. Lin, Janel L. Kopp, David F. Schaeffer
article en

Abstract

Abstract Metabolic diseases, such as type 2 diabetes, insulin resistance, and obesity, often coexist with pancreatic ductal adenocarcinoma (PDAC) and predict poor survival. Using a mouse model of diet-induced obesity, we showed that a high-fat diet (HFD) consumption that induces hyperinsulinemia, but not hyperglycemia, in mice accelerated the growth of xenografted patient-derived PDAC organoids (PDOs). Strikingly, even in the fasting state, insulin was highly enriched in the tumor interstitial fluid of pancreatic tumors under HFD. Modelling this elevated interstitial insulin concentration in vitro significantly increased PDO growth regardless of glucose levels. Mechanistically, chronic high-insulin exposure robustly enhances metabolic plasticity and nutrient utilization in PDOs by selectively upregulating distinct metabolic pathways in response to differences in extracellular glucose levels. Thus, the presence of robust insulin levels continuously supports tumor growth as glucose availability changes. Specifically, under low-glucose conditions, elevated insulin activates nutrient uptake machinery and amino acid metabolism, whereas it promotes aerobic glycolysis in high-glucose conditions. Pharmacological inhibition of these metabolic pathways attenuated insulin-mediated growth. Our study identifies insulin enrichment in the tumor-interstitial fluid as an important driver of metabolic adaptation in PDAC cells. Citation Format: Jeffrey SH. Lin, James D. Johnson, Christoph H. Borchers, David F. Schaeffer, Janel L. Kopp. Interstitial insulin enrichment drives pancreatic cancer growth by enhancing cancer cell metabolic plasticity [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_3):Abstract nr A032.

Cancer ResearchVol. 85(18_Supplement_3)
University of British Columbia (CA), Jewish General Hospital (CA)
Openalex Percentile: Top 67%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.